References
- Chen Y, Hui H, Yang H, Zhao K, Qin YS, Gu C, Wang XT, Lu N, Guo QL. 2013. Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells. Blood. May 2;121:3682–3691.
- Chen Y, Li M, Li ZJ, Gao P, Zhou X, Zhang JX. 2016. Bufalin induces apoptosis in the U-2OS human osteosarcoma cell line via triggering the mitochondrial pathway. Mol Med Rep. Jan;13:817–822.
- Chung H, Choi HS, Seo EK, Kang DH, Oh ES. 2015. Baicalin and baicalein inhibit transforming growth factor-beta 1-mediated epithelial-mesenchymal transition in human breast epithelial cells. Biochem Biophys Res Commun. Mar 13;458:707–713.
- He A, Yang X, Huang Y, Feng T, Wang Y, Sun Y, Shen Z, Yao Y. 2015. CD133(+) CD44(+) cells mediate in the lung metastasis of osteosarcoma. J Cell Biochem. Aug;116:1719–1729.10.1002/jcb.v116.8
- Lewis VO, Raymond K, Mirza AN, Lin P, Yasko AW. 2006. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response. Clin Orthop Relat Res. Sep;450:60–66.10.1097/01.blo.0000229306.05513.51
- Lin YL, Yang XG, Lu M, Zheng WJ, Zhang J, Zhuang HQ, Hua ZC. 2013. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180. Anti-Cancer Drugs. Oct;24:945–957.10.1097/CAD.0b013e3283651862
- Shu YJ, Bao RF, Wu XS, Weng H, Ding Q, Cao Y, Li ML, Mu JS, Wu WG, Ding QC, et al. 2014. Baicalin induces apoptosis of gallbladder carcinoma cells in vitro via a mitochondrial-mediated pathway and suppresses tumor growth in vivo. Anticancer Agents Med Chem. 14:1136–1145.10.2174/1871520614666140223191626
- Zandueta C, Ormazbal C, Perurena N, Martinez-Canarias S, Zalacain M, Julian MS, Grigoriadis AE, Valencia K, Campos-Laborie FJ, De Las Rivas J, et al. 2016. Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis. J Pathol. Aug;239:438–449.
- Zhang ZC, Shao ZW, Xiong LM, Yang SH. 2015. Inhibition of autophagy enhances cisplatin-induced apoptosis in the MG63 human osteosarcoma cell line Oncology letters. Nov;10:2941–2946.
- Zheng SE, Zhou SH, Qiao GL, Yang QC, Zhang ZC, Lin F, Min DL, Tang LN, Li HT, Sun YJ, et al. 2015. Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma. Am J Cancer Res. 5:411–422.